lysozyme hydrochloride - pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23312331JP XVII Ultraviolet-visible Reference Spectra

Lysozyme Hydrochloride

Manidipine Hydrochloride

Maprotiline Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23322332 JP XVIIUltraviolet-visible Reference Spectra

Meclofenoxate Hydrochloride

Mecobalamin 1

Mecobalamin 2

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23332333JP XVII Ultraviolet-visible Reference Spectra

Medazepam

Medroxyprogesterone Acetate

Mefenamic Acid

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23342334 JP XVIIUltraviolet-visible Reference Spectra

Mefloquine Hydrochloride

Mefruside

Melphalan

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23352335JP XVII Ultraviolet-visible Reference Spectra

Mepenzolate Bromide

Mepivacaine Hydrochloride

Mequitazine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23362336 JP XVIIUltraviolet-visible Reference Spectra

Mercaptopurine Hydrate

Mestranol

Metformin Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23372337JP XVII Ultraviolet-visible Reference Spectra

Methotrexate

Methoxsalen

Methyldopa Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23382338 JP XVIIUltraviolet-visible Reference Spectra

dl-Methylephedrine Hydrochloride

Methylergometrine Maleate

Methylprednisolone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23392339JP XVII Ultraviolet-visible Reference Spectra

Methylprednisolone Succinate

Methyltestosterone

Meticrane

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23402340 JP XVIIUltraviolet-visible Reference Spectra

Metildigoxin

Metoclopramide

Metoprolol Tartrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23412341JP XVII Ultraviolet-visible Reference Spectra

Metronidazole

Metyrapone

Mexiletine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23422342 JP XVIIUltraviolet-visible Reference Spectra

Miconazole

Miconazole Nitrate

Midecamycin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23432343JP XVII Ultraviolet-visible Reference Spectra

Midecamycin Acetate

Minocycline Hydrochloride

Mitiglinide Calcium Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23442344 JP XVIIUltraviolet-visible Reference Spectra

Mitomycin C

Mizoribine

Montelukast Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23452345JP XVII Ultraviolet-visible Reference Spectra

Morphine Hydrochloride Hydrate 1

Morphine Hydrochloride Hydrate 2

Morphine Sulfate Hydrate 1

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23462346 JP XVIIUltraviolet-visible Reference Spectra

Morphine Sulfate Hydrate 2

Mosapride Citrate Hydrate

Nabumetone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23472347JP XVII Ultraviolet-visible Reference Spectra

Nadolol

Nafamostat Mesilate

Naftopidil

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23482348 JP XVIIUltraviolet-visible Reference Spectra

Nalidixic Acid

Naloxone Hydrochloride

Naproxen

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23492349JP XVII Ultraviolet-visible Reference Spectra

Nateglinide

Neostigmine Methylsulfate

Nicardipine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23502350 JP XVIIUltraviolet-visible Reference Spectra

Nicergoline

Niceritrol

Nicomol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23512351JP XVII Ultraviolet-visible Reference Spectra

Nicorandil

Nicotinamide

Nicotinic Acid

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23522352 JP XVIIUltraviolet-visible Reference Spectra

Nifedipine

Nilvadipine

Nitrazepam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23532353JP XVII Ultraviolet-visible Reference Spectra

Nitrendipine

Nizatidine

Noradrenaline

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23542354 JP XVIIUltraviolet-visible Reference Spectra

Norfloxacin

Nortriptyline Hydrochloride

Noscapine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23552355JP XVII Ultraviolet-visible Reference Spectra

Nystatin

Ofloxacin

Olmesartan Medoxomil

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23562356 JP XVIIUltraviolet-visible Reference Spectra

Olopatadine Hydrochloride

Omeprazole

Orciprenaline Sulfate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23572357JP XVII Ultraviolet-visible Reference Spectra

Oxazolam

Oxethazaine

Oxybuprocaine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23582358 JP XVIIUltraviolet-visible Reference Spectra

Oxycodone Hydrochloride Hydrate

Oxymetholone

Oxytetracycline Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23592359JP XVII Ultraviolet-visible Reference Spectra

Oxytocin

Ozagrel Sodium

Panipenem